Drug intelligence / Profile preview

Salmovac

Development stage
Unknown
Lead developer
IDT Biologika
Modality
Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Oral
01

Overview

Salmovac is a live attenuated vaccine designed for active immunization of poultry, specifically chickens (layers, layer breeders, and broiler breeders). It contains a genetically stable, double-attenuated (adenine-histidine auxotrophic) Salmonella Enteritidis mutant strain (strain 441/014). Administered orally via drinking water, the vaccine stimulates both cell-mediated immunological mechanisms and antibody formation in chickens. This immune response provides protection against salmonellosis by reducing the colonization, persistence, and invasion of the intestinal tract and internal organs by both Salmonella Enteritidis and Salmonella Typhimurium. Originally developed by IDT Biologika GmbH, Salmovac is now manufactured and marketed by Ceva Santé Animale following an acquisition.

Brand names
Salmovac 440Salmovac440Salmovac-440Cevac Salmovac

Beyond the preview

Go deeper on Salmovac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmovac.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call